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Introduction
Cephalosporins are among the most widely used group of antibacterial in veterinary and human medical practice. Cefepime, a new fourth generation cephalosporin, with a modified zwitterionic structure that allows more favorable penetration into the bacterial cells, higher affinity for its molecular target (PBP3) and reduced susceptibility to β-lactamases (Del et al., 2008) . Cefepime is unique because of its broad spectrum of activity that includes gram-positive cocci, enteric gram-negative bacilli and Pseudomonas (Sultana and Arayne, 2007, Ozbek and Otuk, 2010) . It has advantage of activity against some Extended-spectrum β-lactamase (ESBL)-producing strains of Klebsiella and E. coli that have become resistant to many other β-lactam drugs and fluoroquinolones (Riviere and Papich, 2009) . In view of the species variation in the disposition kinetic data of antimicrobials, it is considered important to investigate the disposition kinetics of drugs in different animal species and under different environmental conditions. cefepime have been described in various animals species as in rabbits (Abd EL-Aty et al., 2007 , Rule et al.,2010 , rats and monkeys (Forgue et al., 1987,Klesel and seeger 1983 ) , Foals and dogs (Gardner and Papich 2001) , buffalo calves Sharma 2009 ) , cow calves (Patel et al.,2006 ,Patil et al.,2012 , goats (EL-Rabbat et al.,2010) , sheep and horses (Guglick et al.,1998) . Currently, there are no available data on the pharmacokinetics of cefepime in broiler chickens. Salmonella typhimurium (S. typhimurium) is a pathogenic Gram-negative bacterium predominately found in the intestinal lumen. Salmonellosis among domestic animals may range from latent (in-apparent) to severe and fatal, the latter especially in young animals. Symptoms vary but usually include weakness, prostration, fever, and diarrhea. Pregnant animals may abort. Convulsions may occur in cattle. Salmonella typhimurium causes disease in horses, cattle, sheep, and chickens (Ryan et al., 2013) . The aim of this study is to describe the pharmacokinetic behaviour of cefepime in serum of healthy and experimentally infected broiler chickens with Salmonella typhimurium after single intravenous (IV) and intramuscular (IM) administration. 2-Chickens: This study was conducted on 24 apparently normal Salmonella typhimurium free white leghorn broiler chickens of 1.5±0.2 kg (35 days age). All chickens were obtained from El-Arabia poultry breeding farm. They were divided into 4 groups, were housed in plastic cages. Chickens were fed on balanced drug free ration for two weeks to ensure complete excretion of any drugs from their bodies. Water was supplied ad-libitum. Chickens were injected with cefepime at dose 100 mg/kg b.wt according to (Feizi et al., 2009 
Materials and methods Materials

3-Experminetal design:
Chickens were grouped into 4 groups (each group 6 chickens) as shown in Table 1 .
Groups
No./group Group and Treatment Gr1 6 Apparently normal chickens were injected intravenously (IV) with a single dose of 100 mg / kg. b. w. into the right-wing vein.
Gr2
6 Apparently normal chickens were injected intramuscularly (IM) with a single dose of 100 mg / kg. b. w. into the thigh muscle.
Gr3
6
Experimentally Salmonella typhimurium infected chickens were injected IV with a single dose of 100 mg / kg. b. w. into the right-wing vein after appearance of clinical symptoms.
Gr4
6
Experimentally Salmonella typhimurium infected chickens were injected IM with a single dose of 100 mg / kg. b. w. into the the thigh muscle after appearance of clinical symptoms.
4-Salmonella typhimurium strain: Salmonella typhimurium strain of poultry origin obtained from poultry department, Animal Health Research Institute, Dokki, Giza, Egypt is used for experimental infection. Clinical signs (ruffled feathers, diarrhea, loss of appetite and thirst) were appear after given an oral inoculation with 10 12 live S. typhimurium (Wendy et al., 1998 ) and transferred to a pen (1.5m
2 ) of fresh litter in an isolation room. 5-Samples: Blood samples (0.5 to 1 ml/sample) were collected from the leftwing vein of each chicken into clean test tubes at zero time (0) prior to injection and then, at 5,10,15, and 30 minutes and 1, 2, 4, 8, 10, 12 and 24 hours after injection. All blood samples were centrifuged at 3500 rpm for 10 minutes, and sera were harvested and stored frozen at -20 ºC until analyzed for cefepime. Methods Cefepime was extracted from serum according to the method described by (Dog˘An et al., 2013) . The concentration of cefepime was determined by high performance liquid chromatography (HPLC) according to (Jimenez Palacios et al., 2005 ). An aliquot of 500 µL of chicken serum was added in an epindorf tube, then total volume was completed to 1 mL with addition of 10% TCA. After centrifugation at 6,000 rpm for 5 min, supernatants were filtrated with 0.45 µm and transferred into the autosampler vial for analysis.
Reagents and Solvents:
All reagents were of analytical grade. Methanol was of HPLC grade. Sodium dihydrogen phosphate and dibasic sodium phosphate were obtained from Merck (Barcelona, Spain). Deionized water was used.
Instrument and Analytical Conditions:
Agilent series 1200 quaternary gradient pump, series 1200 autosampler, series 1200 UV Vis detector, eclipse XDB C18 column (5µm, 4.6mm, 250mm). The mobile phase consisted of 10mM phosphate buffer (pH 7): Methanol; 75:25 was always freshly prepared. Flow rates were 1 ml/min. UV detection was performed at 256nm, injection volume was 20 µl.
Preparation of standard curves of cefepime in serum:
A stock solution 1000 μg/ml of cefepime in deionized water was prepared. All stock solutions were stored at +4 0 C. Working solutions of cefepime used to spike serum were prepared at 10.00, 1.00 and 0.10 µg/ml concentrations from stock solutions by diluting with deionized water. Standard concentrations were obtained by further dilution in drug free normal chicken serum to obtain concentrations 0.18, 1, 5, 10, 25, 50, 75, and 100µg/ml for establishment of standard curve of cefepime according to (Dog˘An et al., 2013) . Cefepime was assayed in serum by the HPLC assay as previously mentioned.
Pharmacokinetic analysis:
The pharmacokinetic parameters were calculated by PK Solver: An add-in program for Microsoft Excel, version 2 (Zhang et al., 2010) .
Statistical Analysis:
The data were calculated as mean ± standard deviation. All statistical analysis was carried out according to (Berly and Lindgren, 1990 ) using Student's (t) probability test to express the differences between healthy and infected groups.
Results
The different concentrations 0.18, 1.00, 5.00, 10.00, 25.00, 50.00, 75.00, and 100.00 µg/ml of cefepime in antibiotic free chicken's serum and the retention time are presented in (Table 2 
Recovery:
The percentage recovery of cefepime spiked serum samples ranged from 96-98 %. Retention time: The retention time of cefepime from serum was 1.666 min. Zhang et al., 2010 . A, zero-time intercept of the distribution slope. B, zero-time intercept of decline in serum concentration of drug. α, distribution rate constant. β, elimination rate constant. k10, first-order elimination rate constant from central compartment. k12, rate constant for passage from central to peripheral compartment. k21, rate constant for passage from peripheral to central compartment. t1/2α, the distribution half-life.t1/2β, elimination half-life. C 0 , plasma drug concentration at t=0(Immediately) following drug administration. AUC 0-t, area under the [plasma drug concentration versus time] curve. AUC 0-∞, total area under the concentration-time curve from zero to infinity. AUMC, area under the first moment curve. MRT, mean residence time. Cl, total body clearance. CL2, Inter-compartmental clearances. V1, apparent volume of central compartment. V2, apparent volume of peripheral compartment. Significant at* P ≤ 0.05 **P ≤ 0.01 ***P ≤ 0.001 when compared with respective values of cefepime (IV) healthy and disease chickens. Following a single IV injection of 100mg cefepime /kg b. wt. in healthy and disease chickens, Cefepime was detected in serum in a therapeutic level for 24 hours with mean values of 4.28 ± 0.37μg/ml and 2.62 ± 0.72 μg/ml respectively (Table 5 and Fig. 4 ) and exceed the MIC of S. typhimurium which was ≤ 0.12 μg/ml.
The serum concentration-time data of cefepime (100 mg/kg b.wt) following IV injection in normal chickens was best fitted to a two compartments open model. The pharmacokinetic parameters of cefepime after a single IV injection in healthy and diseased chickens, ( while its passage from the peripheral to the central compartment at a rate constant (K21) was 2.278 ± 0.378 h -1 and 1.74 ± 0.69 h -1 . The volume of the central compartment distribution (V1) was 0.417 ± 0.006 and 0.505 ± 0.019 (mg/kg)/(μg/ml), whereas the volume of the peripheral compartment distribution (V2) was 0.169 ± 0.009 and 0.188 ± 0.015 (mg/kg)/(μg/ml)/h . The volume of distribution at steady state (Vdss) was 0.586 ± 0.11 and 0.694±0.016 (mg/kg)/(μg/ml). Cefepime was eliminated after IV injection with half-life (t1/2β) value of 4.608 ± 0.145 h and 4.19 ± 0.158 h and cleared by all clearance processes (CL) in the body at a rate 0.090 ± 0.002 and 0.118 ± 0.002 (mg/kg)/(μg/ml)/h. The area under the serum concentration time curve (AUC0-t) of cefepime after IV administration was 1081.41±20.50 and 829.91 ± 12.68 μg/ml.h. Following a single IM administration of cefepime (100 mg / kg b.wt.), the drug reached its maximum serum concentrations(Cmax) 193.06 ± 2.27 μg/ml after 1.138 ± 0.012 h post administration (Tmax)in healthy chickens while in diseased chickens the (Cmax) was 132.93 ± 1.53 μg/ml after 1.265 ± 0.013 h post administration(Tmax).
Cefepime was detected in serum in a therapeutic level for 24 hours with mean value 2.28±0.32 in healthy chickens, 1.32 ± 0.30 in diseased chickens (Table 4 & in healthy chickens while in diseased chickens was 1.42 ± 0.29 h -1 while absorption half-life (t1/2ab) was 0.491 ± 0.027 h in healthy chickens, in diseased chickens absorption half-life (t1/2ab) was 0.506 ± 0.092 h. Cefepime reached its maximum concentrations (Cmax) 193.06 ± 2.27 μg/ml after maximum time equal to (Tmax) 1.138 ± 0.012 h in healthy chickens , in diseased chickens the maximum concentrations (Cmax) of 132.93 ± 1.53 μg/ml at maximum time equal to (Tmax) 1.265 ± 0.013 h . Cefepime was eliminated at a rate (K10) equal to 0.321 ± 0.016 h. The elimination half-life (t1/2β) was 3.670 ± 0.125 h in healthy chickens, while in diseased chickens the eliminated at a rate (K10) was 0.295 ± 0.046 h and the elimination half-life t1/2β was 3.63 ± 0.476 h. Cefepime was cleared by all clearance processes (Cl/F) in the body at rate of 0.088 ± 0.001 (mg/kg)/(μg/ml)/h. The area under serum concentration time curve of cefepime after a single IM administration (AUC0-t) was 1127.58 ± 14.48 μg/ml.h in healthy chickens. In diseased chickens, cefepime was cleared by all clearance processes (CL/F) in the body was 0.127 ± 0.003 (mg/kg) /(μg/ml)/h. The area under serum concentration time curve of cefepime after a single IM administration (AUC0-t) was 781.20 ± 16.25 μg/ml. Comparison between serum concentration of cefepime in normal and Salmonella typhimurium infected chickens following IV and IM injection:
After IV and IM administration there was a significant (P≤0.001) decrease in serum concentration of cefepime in S. typhimurium infected chickens as compared to healthy ones (Table 5) . (Chong et al.,1993) with reduced susceptibility to extendedspectrum β-lactamases (Jacoby and Cerreras, 1990) . In the present investigation, the drug disposition after i.v and i.m administration of (100 mg/kg) in chickens was best fitted by a two-compartment open model. The
two-compartments open model was reported to be the best to describe the disposition of cefepime sheep following i.v administration of 20 mg/kg , goats following i.v administration of 10 mg/kg and co-administration with flunixin (El-Hewaity, 2014). However, the non-compartmental analysis was used for cefepime disposition in ewes after i.m injection of 20 mg/kg (Ismail, 2005a) , rabbits after i.m injection and i.v injection (Abd El-Aty et al., 2007 , Rule et al., 2010 . Moreover, the serum concentration of cefepime was fitted to one-compartment open model in buffalo calves following IM administration of 10 mg/kg , goats after IV and IM administration of 10 mg/kg . Following a single IV administration, the half-life of distribution (t1/2α) was very short (0.217 ± 0.036 h) in healthy broiler chickens injected with cefepime in a single dose of 100 mg/kg. The distribution half-life is closely similar to cefepime that previously reported in goats (0.20 ± 0.004 h, ElHewaity, 2014), buffalo calves (0.18 ± 0.05 h, Joshi and Sharma, 2007) , sheep (0.2 ± 0.02 h, , calves (0.2 ± 0.02 h; 0.25 ± 0.07 h, Pawar and Sharma, 2008) and ewes (0.18 ± 0.008 h, Ismail, 2005a) . Longer half-life of distribution was recorded for cefepime in bull camels (0.30 ± 0.05h, Goudah et al., 2009) , and neonatal foals and adult dogs (0.30 ± 0.16 h; 0.39 ± 0.21 h, Gardner and Papich, 2001) respectively. In this study, the results showed that cefepime serum concentration (μg/ml) after single IV injections into Salmonella typhimurium infected chickens were generally lower than that in healthy ones. This indicates that cefepime disappeared more rapidly from blood of diseased than healthy chickens. This is confirmed by the rapid transfer of the drug from the central to the peripheral compartment in diseased than in normal chickens (K12, 0.664 ± 0.342 h ) in healthy. The most likely explanation of the decreased serum concentration is the wide distribution of the drug in the body of diseased than in healthy chickens. This suggestion is confirmed by the larger volume of distribution (Vdss) of cefepime in diseased (0.694 ± 0.016) than in healthy chickens (0.586 ± 0.11 mg/kg (μg/ml). Moreover, the cefepime is rapidly eliminated from the body of diseased than normal chickens (Cl, 0.118 ± 0.002) in diseased vs (0.090 ± 0.002 (mg/kg)/(μg/ml)/h in healthy could be another factor for the observed lower serum concentration of cefepime in serum of diseased chickens. This is also confirmed by the short elimination half-life (t1/2β) in diseased (4.19 ± 0.158 h) than that in the healthy birds (4.608 ± 0.145 h). The lower blood concentration, wide distribution and rapid disappearance of cefepime from the serum after single IV injections into Salmonella typhimurium infected chickens than those in normal chickens could be attributed to the higher penetrating power of cefepime to the inflamed tissues. From the previous discussion it could be suggested that cefepime is widely distributed and rapidly eliminated in diseased birds than in healthy ones. The volume of distribution (Vdss) was closely related to cefepime that previously reported in goats (0.44 ± 0.01 mg/kg, ElHewaity, 2014) calves (0.42 ± 0.08; 0.43 ± 0.03; 0.52 ± 0.03 mg/kg, Joshi and Sharma, 2007 , Patel et al., 2006 , Patil et al., 2012 respectively, but higher than that reported in bull camels (0.10 ± 0.04 mg/kg, Goudah et al., 2009) , calves (0.21 ± 0.01 mg/kg, , ewes (0.32 ± 0.01 mg/kg, Ismail, 2005a) and neonatal foals and adult dogs (0.18 ± 0.05; 0.14 ± 0.04 mg/kg, Gardner and Papich, 2001) respectively. The total body clearance (CL) of cefepime following a single IV administration in the present study was (0.090 ± 0.002(mg/kg)/(μg/ml)/h), this obtained result was agreed with cefepime that previously reported in goats (0.098 ± 0.0004 mg/kg/h, (El-Hewaity, 2014), neonatal foals and adult dogs (0.08±0.02; 0.13±0.04 mg/kg/h, (Gardner and Papich, 2001) respectively, but disagreed with those reported for Cefepime in calves (86.1 ± 3.65; 1.81 ± 0.16; 1.1 ± 0.08 mg/kg/h, Joshi and Sharma, 2007 , Patel et al., 2006 , goats (1.1 ± 0.54 mg/kg/h, Prawez et al., 2010) respectively, bull camels (0.04 ± 0.01 mg/kg/h, Goudah et al., 2009) and sheep (2.48 ± 0.09, Patel et al., 2010) .
The elimination half-life (t½β) of cefepime following a single i.v administration (4.6 ± 0.15h) was agreed with that reported in goats (3.34 ± 0.12 h, El-Hewaity, 2014 ), calves (3.7 ± 0.16 h, Patel et al., 2006 but disagreed with those reported in calves (2.67 ± 0.29 ; 2.38 ± 0.16 h, Sharma, 2007, Ismail, 2005b) respectively, bull camels (2.0 ± 0.23 h, Goudah et al., 2009 ), goats (1.86 ± 0.54 h, Prawez et al., 2010 respectively, sheep (2.54 ± 0.12 h, , ewes (1.76 ± 0.07 h, Ismail, 2005a) , rabbits (2. 94 ± 0.16 h, Abd El-Aty et al., 2007) and neonatal foals and adult dogs (1.65 ± 0.10 h ; 1.09 ± 0.27 h, Gardner and Papich, 2001 ) respectively. Following a single IM administration, cefepime was rapidly and efficiently absorbed in chickens. The reported half-life of absorption (t1/2ab) was (0.49±0.03h) which similar to that recorded in cefepime in ewes (0.49±0.05h, Ismail 2005 a). However, it was disagreed with cefepime that previously reported in goats (0.77±0.34; 0.25±0.02; h, Prawez et al., 2010 , El-Hewaity, 2014 respectively, bull camels (2.5 ± 0.27 h, Goudah et al., 2009) and calves (0.29 ± 0.02; 0.17 ± 0.01 h, respectively. Although there was no significant difference in the absorption halflife between diseased and healthy chickens, the serum concentration in diseased chickens was generally lower than healthy ones. Once again, this is due to rapid disappearance of cefepime from the central to the peripheral compartment as confirmed by short K12 in diseased (0.229 ± 0.151 h -1 ) than normal chickens (0.403 ± 0.022 h -1 ). Cefepime reached to a maximum serum concentration (Tmax) after (1.14±0.01 h) which nearly similar to cefepime thatThese differences reflect the difference in the AUC reported in this study. This differences in the AUC is probably because of the differences in the doses used which are consequently reflects the difference in the F%.
Conclusion:
From the present study it could be concluded that, the IM bioavailability of cefepime is excellent and this value revealed a better absorption from its site of IM administration. 
